{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:29:39Z","timestamp":1783132179898,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["#PI12\/02267"],"award-info":[{"award-number":["#PI12\/02267"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00228-018-2569-3","type":"journal-article","created":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T23:55:03Z","timestamp":1538956503000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Incidence of Stevens-Johnson syndrome\/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study"],"prefix":"10.1007","volume":"75","author":[{"given":"Sara","family":"Rodr\u00edguez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mart\u00edn-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rodr\u00edguez-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gonz\u00e1lez-Herrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"de Abajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"2569_CR1","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/bjd.13989","volume":"173","author":"YK Heng","year":"2015","unstructured":"Heng YK, Lee HY, Roujeau JC (2015) Epidermal necrolysis: 60 years of errors and advances. Br J Dermatol 173:1250\u20131254","journal-title":"Br J Dermatol"},{"key":"2569_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/pds.3937","volume":"25","author":"J Diphoorn","year":"2016","unstructured":"Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, Vighi GD, Naldi L, REACT-Lombardia study group (2016) Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf 25:196\u2013203","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2569_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidorodd A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR syudy group (2013) Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Investig Dermatol 133:1197\u20131204","journal-title":"J Investig Dermatol"},{"key":"2569_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schr\u00f6der W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"2569_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Sch\u00f6pf E, Kaufman DW (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600\u20131607","journal-title":"N Engl J Med"},{"key":"2569_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidorodd A, Schneck J, Roujeau JC, Flahault A (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Investig Dermatol 128:35\u201344","journal-title":"J Investig Dermatol"},{"key":"2569_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/pds.3371","volume":"22","author":"N Moore","year":"2013","unstructured":"Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jov\u00e9 J, Pariente A, Blin P, B\u00e9nichou J, B\u00e9gaud B (2013) Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. Pharmacoepidemiol Drug Saf 22:160\u2013167","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2569_CR8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","volume":"64","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J (2005) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64:1134\u20131138","journal-title":"Neurology"},{"key":"2569_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/pds.1264","volume":"15","author":"T Telfair","year":"2006","unstructured":"Telfair T, Mohan AK, Shahani S, Klincewick S, Atsma WJ, Thomas A, Fife D (2006) Estimating post-marketing exposure to pharmaceutical products using ex-factory distribution data. Pharmacoepidemiol Drug Saf 15:749\u2013753","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2569_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J (2005) A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58:323\u2013327","journal-title":"J Clin Epidemiol"},{"key":"2569_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-015-1850-y","volume":"71","author":"E Mart\u00edn-Merino","year":"2015","unstructured":"Mart\u00edn-Merino E, de Abajo FJ, Gil M (2015) Risk of toxic epidermal necrolysis and Stevens-Johnson syndrome associated with benzodiazepines: a population-based cohort study. Eur J Clin Pharmacol 71:759\u2013766","journal-title":"Eur J Clin Pharmacol"},{"key":"2569_CR12","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/epi.13925","volume":"58","author":"N Frey","year":"2017","unstructured":"Frey N, Bodmer M, Bircher A, R\u00fcegg S, Jick SS, Meier CR, Spoendlin J (2017) The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Epilepsia 58:2178\u20132185","journal-title":"Epilepsia"},{"key":"2569_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jid.2017.12.015","volume":"138","author":"N Frey","year":"2018","unstructured":"Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J (2018) Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study. J Investig Dermatol 138:1207\u20131209","journal-title":"J Investig Dermatol"},{"key":"2569_CR14","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/annrheumdis-2017-212905","volume":"77","author":"SF Keller","year":"2018","unstructured":"Keller SF, Lu N, Blumenthal KG, Rai SK, Yokose C, Choi JWJ, Kim SC, Zhang Y, Choi HK (2018) Racial\/ethnic variation and risk factors for allopurinol associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis 77:1187\u20131193","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2569_CR15","doi-asserted-by":"publisher","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","volume":"11","author":"MS Yang","year":"2016","unstructured":"Yang MS, Lee JY, Kim J, Kim G, Kim BK, Kim JY, Park HW, Cho SH, Min KU, Kang HR (2016) Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using National Health Insurance Database in Korea. PLoS One 11(11):e0165933. https:\/\/doi.org\/10.1371\/journal.pone.0165933","journal-title":"PLoS One"},{"key":"2569_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"key":"2569_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","volume":"13","author":"N Mittmann","year":"2012","unstructured":"Mittmann N, Knowles SR, Koo M, Shear NH, Rachlis A, Rourke SB (2012) Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort: an observational, retrospective case series study. Am J Clin Dermatol 13:49\u201354","journal-title":"Am J Clin Dermatol"},{"key":"2569_CR18","unstructured":"The RegiSCAR Project Available at: http:\/\/www.regiscar.org . Accessed 30 Jan 2018"},{"key":"2569_CR19","unstructured":"PIELenRed. ConsorcioPIELenRed Available at: http:\/\/pielenred.hol.es\/PIELenRed\/2015 . Accessed 24 Mar 2018"},{"key":"2569_CR20","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios BIFAP: Base de datos para la Investigaci\u00f3n Farmacoepidemiol\u00f3gica en Atenci\u00f3n Primaria Available at: http:\/\/bifap.aemps.es\/ . Accessed 24 Mar 2018"},{"key":"2569_CR21","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Mart\u00edn S, Mart\u00edn-Merino E, Lerma V, Rodr\u00edguez-Miguel A, Gonz\u00e1lez O, Gonz\u00e1lez-Herrada C, Ram\u00edrez E, Bell\u00f3n T, de Abajo FJ (2018) Active surveillance of severe cutaneous adverse reactions: a case-population approach using a registry and a healthcare database. Pharmacoepidemiol Drug Saf:1\u20139. https:\/\/doi.org\/10.1002\/pds.4622","DOI":"10.1002\/pds.4622"},{"key":"2569_CR22","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonz\u00e1lez-Herrada","year":"2017","unstructured":"Gonz\u00e1lez-Herrada C, Rodr\u00edguez-Mart\u00edn S, Cachafeiro L, Lerma V, Gonz\u00e1lez O, Lorente JA, Rodr\u00edguez-Miguel A, Gonz\u00e1lez-Ramos J, Roustan G, Ram\u00edrez E, Bell\u00f3n T, de Abajo FJ, PIELenRed Therapeutic Management Working Group (2017) Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J Investig Dermatol 137:2092\u20132100","journal-title":"J Investig Dermatol"},{"key":"2569_CR23","first-page":"1","volume":"22","author":"C Huerta","year":"2013","unstructured":"Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H (2013) Prevalence of use of benzodiazepines and related drugs in seven European databases: a cross-national descriptive study from the PROTECT-EU project. Pharmacoepidemiol Drug Saf 22:1\u2013512","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2569_CR24","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/pds.3617","volume":"23","author":"FJ Abajo De","year":"2014","unstructured":"De Abajo FJ, Gil MJ, Garc\u00eda-Poza P, Bryant V, Oliva B, Timoner J, Garc\u00eda-Rodr\u00edguez LA (2014) Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol Drug Saf 23:1128\u20131138","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2569_CR25","doi-asserted-by":"publisher","first-page":"e005795","DOI":"10.1161\/JAHA.117.005795","volume":"6","author":"FJ Abajo De","year":"2017","unstructured":"De Abajo FJ, Rodr\u00edguez-Mart\u00edn S, Rodr\u00edguez-Miguel A, Gil MJ (2017) Risk of ischemic stroke associated with calcium supplements with or without vitamin D: a nested case-control study. J Am Heart Assoc 6:e005795. https:\/\/doi.org\/10.1161\/JAHA.117.005795","journal-title":"J Am Heart Assoc"},{"key":"2569_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00228-012-1386-3","volume":"69","author":"FJ Abajo De","year":"2013","unstructured":"De Abajo FJ, Gil MJ, Bryant V, Timoner J, Oliva B, Garc\u00eda-Rodr\u00edguez LA (2013) Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol 69:691\u2013701","journal-title":"Eur J Clin Pharmacol"},{"key":"2569_CR27","unstructured":"Instituto de Estad\u00edstica. Comunidad de Madrid. Available at: http:\/\/www.madrid.org\/iestadis\/fijas\/otros\/estructu_cen.htm . Accessed 10 Jan 2018"},{"key":"2569_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H (2010) ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 88:60\u201368","journal-title":"Clin Pharmacol Ther"},{"key":"2569_CR29","unstructured":"Council for International Organisations of Medical Sciences (1995) Guidelines for preparing core clinical safety information on drugs. Geneva: CIOMS. Available at: https:\/\/cioms.ch\/shop\/product\/guidelines-preparing-core-clinical-safety-information-drugs-second-edition-report-cioms-working-groups-iii-v\/ . Accessed 16 June 2018"},{"key":"2569_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","volume":"167","author":"HY Lee","year":"2012","unstructured":"Lee HY, Dunant A, Sekula P, Mockenhaupt M, Wolkenstein P, Valeyrie-Allanore L, Naldi L, Halevy S, Roujeau JC (2012) The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies. Br J Dermatol 167:555\u2013562","journal-title":"Br J Dermatol"},{"key":"2569_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, Naldi L, Dunant A, Viboud C, Roujeau JC, EuroSCAR Study Group (2008) Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58:25\u201332","journal-title":"J Am Acad Dermatol"},{"key":"2569_CR32","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","volume":"175","author":"CY Yang","year":"2015","unstructured":"Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH (2015) Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med 175:1550\u20131557","journal-title":"JAMA Intern Med"},{"key":"2569_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/FPC.0000000000000285","volume":"27","author":"N Saksit","year":"2017","unstructured":"Saksit N, Tassaneeyakul W, Nakkam N, Konyoung P, Khunarkornsiri U, Chumworathayi P, Sukasem C, Suttisai S, Piriyachananusorn N, Tiwong P, Chaiyakunapruk N, Sawanyawisuth K, Rerkpattanapipat T, Tassaneeyakul W (2017) Risk factors of allopurinol-induced severe cutaneous reactions in Thai population. Pharmacogenet Genomics 27:255\u2013263","journal-title":"Pharmacogenet Genomics"},{"key":"2569_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2165\/00128071-200304080-00006","volume":"4","author":"N Bachot","year":"2003","unstructured":"Bachot N, Roujeau JC (2003) Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 4:561\u2013572","journal-title":"Am J Clin Dermatol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2569-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:50:18Z","timestamp":1775242218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2569"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2569-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all prospective individual participants or legal representatives. For retrospective cases, the Ethics Research Committee granted us an exemption. BIFAP is a fully anonymised database, and according to the Spanish law, an informed consent is not required when no personal data is collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}